Levin Capital Strategies, L.P. Pulse Biosciences, Inc. Transaction History

Levin Capital Strategies, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	BUY	$22.43 - $44.27 $12,964 - $25,588	578 Added 2.99%	19,939 $472,000
Q3 2020 Nov 17, 2020	BUY	$9.27 - $13.14 $3,346 - $4,743	361 Added 1.9%	19,361 $228,000
Q2 2020 Aug 13, 2020	BUY	$6.23 - $13.09 $24,920 - $52,360	4,000 Added 26.67%	19,000 $199,000
Q3 2017 Nov 13, 2017	BUY	$10.26 - $24.97 $153,900 - $374,550	15,000	15,000 $279,000

5.41M

139K

84.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $742M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

Stay updated on Levin Capital Strategies, L.P. with notifications on news.